Garcia, Gabriela

USPTO Trademark & Patent Filings

Garcia Gabriela

Trademark applications and grants for Garcia, Gabriela. Garcia, Gabriela has 2 trademark applications. The latest application filed is for "CLOCKCHOICE"

Company Profile
    Company Aliases
  • Garcia, Gabriela
  • gabriela garcia
  • GARCIA; Gabriela - Roslindale MA
  • Garcia; Gabriela - Roslindale MA
  • Garcia; Gabriela - Denver CO
Entity Type INDIVIDUAL
Address Av. Juracy Magalhaes Jr. Salvador BRAZIL 41940060

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS
20190119401 - 15/994393 MOYO; Victor ;   et al.
2019-04-25
USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS
20170291957 - 15/346439 MOYO; Victor ;   et al.
2017-10-12
OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS
20150231238 - 14/004848 Garcia; Gabriela ;   et al.
2015-08-20
USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS
20150132292 - 14/518900 MOYO; Victor ;   et al.
2015-05-14
USE OF INHIBITORS OF EGFR-FAMILY RECEPTORS IN THE TREATMENT OF HORMONE REFRACTORY BREAST CANCERS
20140134170 - 14/004598 Garcia; Gabriela ;   et al.
2014-05-15
Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers
9,518,130 - 14/518,900 Moyo , et al. December 13, 2
2016-12-13
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
8,895,001 - 13/583,949 Moyo , et al. November 25, 2
2014-11-25
Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
8,895,001 - 13/583,949 Moyo , et al. November 25, 2
2014-11-25
Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
8,697,628 - 13/521,881 Garcia , et al. April 15, 2
2014-04-15
Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
8,697,628 - 13/521,881 Garcia , et al. April 15, 2
2014-04-15
Patent Grants & Applications
Trademark Applications
Company Registrations
SEC0001676283Garcia Gabriela

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed